Home › Calculator › OCS Dividend Calculator 2026
OCS Dividend DRIP Calculator 2026
16.43% YieldHealthcareOculis Holding AG · NASDAQ
Price: $12.17 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When OCS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your OCS snowball 📈
$10,000 in OCS → $45.8K in 10 years · $538.61/month
About Oculis Holding AG (OCS) — Dividend Analysis 2026
Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic macular edema. Additionally, OCS-02, a topically administered biological candidate, is engaged in Phase 2b clinical studies to treat keratoconjunctivitis sicca, commonly known as dry eye disease. The company is also advancing OCS-05, an innovative neuroprotective agent, which targets acute optic neuritis and an array of other neuro-ophthalmic disorders, including glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. This enterprise maintains its headquarters in Zug, Switzerland.
Compare OCS with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full OCS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open OCS position with:
🌍 OCS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold OCS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 16.43% | 13.63% | $1,643 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 13.97% | 11.17% | $1,397 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 13.14% | 10.34% | $1,314 / yr |
| 🇬🇧 UK ISA | 0% | 16.43% | 13.63% | $1,643 / yr |
| 🇬🇧 UK Taxable | 8.75% | 14.99% | 12.19% | $1,499 / yr |
| 🇨🇦 TFSA | 0% | 16.43% | 13.63% | $1,643 / yr |
| 🇨🇦 CA Taxable | 25% | 12.32% | 9.52% | $1,232 / yr |
| 🇦🇺 Super (pension) | 15% | 13.97% | 11.17% | $1,397 / yr |
| 🇦🇺 AU Taxable | 30% | 11.50% | 8.70% | $1,150 / yr |
| 🇩🇪 DE Taxable | 26.375% | 12.10% | 9.30% | $1,210 / yr |
| 🇫🇷 FR Taxable | 30% | 11.50% | 8.70% | $1,150 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 OCS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 OCS Dividend Payment Schedule
OCS pays quarterly — 4 times per year. Next ex-div: TBD.
📊 OCS vs Healthcare Benchmarks
How OCS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OCS sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ OCS Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OCS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Oculis Holding AG (OCS) is currently trading at $12.17, 58% below its 52-week high. The current dividend yield is 16.43% based on an annual payout of $2.00 per share.
OCS (Oculis Holding AG) — 16.43% Dividend Yield Analysis
Oculis Holding AG (OCS) is a healthcare stock currently trading at $12.17 with a dividend yield of 16.43%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (16.43%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.